Uncovering the mode of action of engineered T cells in patient cancer organoids

Keyphrases

• Cancer Organoids 100%
• Mode of Action 100%
• Engineered T Cells 100%
• Solid Tumors 66%
• T Cells 66%
• Cellular Immunotherapy 66%
• Engager 66%
• Cell Therapy 33%
• Immune Cells 33%
• Patient-derived 33%
• Organoids 33%
• Tumor Organoids 33%
• Phenotypic Heterogeneity 33%
• In Vitro Model 33%
• Gene Signature 33%
• Cell Culture 33%
• Specific Genes 33%
• Blood Cancer 33%
• Transcriptomics 33%
• Metabolomics 33%
• T Cell Activation 33%
• Type I Interferon 33%
• Cell Concept 33%
• Solid Tumor Targeting 33%
• Dynamic Interaction 33%
• Targeted Cells 33%
• Serial Killing 33%
• Therapeutic Modes 33%
• Behavioural Clusters 33%

Immunology and Microbiology

• T Cell 100%
• Organoid 100%
• Immunotherapy 33%
• Cell Function 16%
• Immunocompetent Cell 16%
• Transcriptomics 16%
• interferon 16%
• Metabolome 16%

Biochemistry, Genetics and Molecular Biology

• T Cell 100%
• Immunocompetent Cell 16%
• Cell Function 16%
• Transcriptomics 16%
• Gene Signature 16%
• Phenotypic Heterogeneity 16%
• Metabolome 16%
• Interferon Type I 16%